APOE4 dysregulates autophagy in cultured cells
Human APOE4 (apolipoprotein E4 isoform) is a powerful genetic risk factor for late-onset Alzheimer disease (AD). Many groups have investigated the effect of APOE4 on the degradation of amyloid β (Aβ), the main component of plaques found in the brains of AD patients. However, few studies have focused...
Main Authors: | Gianna M. Fote, Joan S. Steffan |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2022-12-01
|
Series: | Autophagy Reports |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/27694127.2022.2040767 |
Similar Items
-
The Endosomal–Lysosomal Pathway Is Dysregulated by APOE4 Expression in Vivo
by: Tal Nuriel, et al.
Published: (2017-12-01) -
Modulating Chaperone-Mediated Autophagy and Its Clinical Applications in Cancer
by: Virginie Hubert, et al.
Published: (2022-08-01) -
APOE4 is associated with cognitive and pathological heterogeneity in patients with Alzheimer’s disease: a systematic review
by: Sheina Emrani, et al.
Published: (2020-11-01) -
The APOEε3/ε4 Genotype Drives Distinct Gene Signatures in the Cortex of Young Mice
by: Kate E. Foley, et al.
Published: (2022-03-01) -
Microglial APOE4: more is less and less is more
by: Ghazaleh Eskandari-Sedighi, et al.
Published: (2023-12-01)